Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New system for diagnosing lymphoma in dogs
West Highland Terrier
Nearly a quarter of dogs will develop cancer in their lifetime. Of these, 20 per cent will be lymphoma cases.

Novel approach offers fresh hope for beloved family pets

Researchers from the University of Leicester have partnered up with Avacta Animal Health Ltd develop a novel electronic system for diagnosing the early stages of lymphoma in dogs, and for remission monitoring.  

The canine lymphoma blood test (cLBT) is the first its kind to monitor the remission status of a dog after chemotherapy.

The university team, led by Professor Alexander Gorban from the mathematics department, worked with experts from Avacta to develop technology for the differential diagnosis of canine lymphoma and remission monitoring.

The cLBT detects the levels of two biomarkers, the acute phase proteins Haptoglobin and C-Reactive Protein.

Having gathered a considerable library of biological samples,  Avacta tested the data by utilising the University of Leicester's leading statistical and data processing techniques. The team
selected their approach by analysing clinical data and testing various machine learning methods.

Prof. Alexander Gorban said: “This was a very interesting project, and Avacta was a very dedicated, focused company, with clear goals and objectives. There were very important and useful ideas and concepts involved in the study, and it was a pleasure to know that our expertise as a department was needed and could be utilised through working alongside Avacta’s professional expertise.

“The project was very successful, and we would be very glad to welcome more partnerships of this type as it has also been very beneficial to the reputation of the University of Leicester’s Department of Mathematics. The project involved full academic and commercial success, which has included a full academic cycle as well as full software development, which makes it an incredibly diverse project to have worked on.”

Kevin Slater, chief scientific officer at Avacta Animal Health, said: “The collaboration we have with the University of Leicester’s Department of Mathematics is having a dramatic impact on the types of new tests that we can offer to vets and their owners.  We are already widening the application of multivariate analysis to other diseases which commonly affect our pets, and subsequently, this work could also have benefits to human health.”

The paper ‘Computational diagnosis and risk evaluation for canine Lymphoma’ by E.M. Mirkes, I. Alexandrakis, K. Slater, R. Tuli and A.N. Gorban has been published in the academic journal Computers for Biology and Medicine

Image (C) Avacta Animal Health Ltd.

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.